箭头公司最新公告

齐欢畅2

Arrowhead Added to NASDAQ Biotechnology Index®
PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (NASDAQ: NBI) as part of the annual re-ranking which will become effective prior to market open on Monday, December 21, 2015.
The NASDAQ Biotechnology Index is designed to track the performance of a set of securities listed on The NASDAQ Stock Market® that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark. The NASDAQ Biotechnology Index is calculated under a modified capitalization-weighted methodology and ranked on an annual basis. All securities in the NASDAQ Biotechnology Index are listed on the NASDAQ Global Market or the NASDAQ Global Select Market and must meet certain eligibility requirements.
For more information about the NASDAQ Biotechnology Index, including eligibility criteria, visit www.nasdaq.com.

齐欢畅2

Arrowhead Reports Fiscal 2015 Year End Results

- Conference Call and Webcast Today at 4:30 p.m. EST

PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Research Corporation (NASDAQ: ARWR) today announced financial results for its fiscal 2015 fourth quarter and year ended September 30, 2015. The company is hosting a conference call at 4:30 p.m. EST to discuss results.

Conference Call and Webcast Details

Investors may access a live audio webcast on the Company's website at http://ir.arrowheadresearch.com/events.cfm. For analysts that wish to participate in the conference call, please dial 855-215-6159 or 315-625-6887 and enter Conference ID 99535530.

A replay of the webcast will be available on the company's website approximately two hours after the conclusion of the call and will remain available for 90 days. An audio replay will also be available approximately two hours after the conclusion of the call and will be available for 3 days. To access the audio replay, dial 404-537-3406 and enter Conference ID 99535530.

Fiscal 2015 Fourth Quarter and Recent Company Highlights

fs2002

没学过英语，看不懂唉

hao2014

难怪没人翻译

列入纳斯达克生物指数
公布财务报表

就这两件事，基本没什么用

hbv_challenger

呵呵呵，小事一桩，不值得发新贴，参考StephenW的贴
，含金量高。